TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research ...

Anne Wojcicki, the co-founder and former CEO of 23andMe, will purchase the bankrupt company’s assets for $305 million, the genetic testing company said Friday. Regeneron Pharmaceuticals had agreed to ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...

A nonprofit backed by the DNA-testing firm's former CEO, Anne Wojcicki, bid $305 million to take control of the company.

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a higher bid. The private-equity firm plans to bid against rival Advent ...

Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.

Me co-founder and former CEO Anne Wojcicki is set to buy back the company after it filed for Chapter 11 bankruptcy protection earlier this year. On Friday, 23andMe and TTAM Research Institute, a ...

Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

WilmerHale shouldn’t be permitted to represent a law professor making privacy-related recommendations about the sale of 23andMe’s customers’ genetic data while also performing work for bidder ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...